EAE is induced because of inflammation of central nervous system (CNS) primarily caused by autoreactive CD4+ T cells. It is well documented that myelin-specific T cells, especially TH1 cells and more recently TH17 cells, are important in the initiation of tissue inflammation in EAE. We have demonstrated that IL-27, a member of the IL-12 family of cytokines, directly suppresses the induction of TH17 cells and generates regulatory IL-10-producing type 1 regulatory T (Tr1) cells. However, the mechanism by which IL-27 mediates inhibition of TH17 cells and promotion of Tr1cells is not well understood. In vivo administration of IL-27 suppresses the development of Th17 cells and EAE. Our preliminary data suggests that IL-27 controls tissue inflammation in EAE by two different but interlinked mechanisms: 1, by inducing the expression of IL-12R?2, and therefore inhibiting the generation of Th17 cells in an IL-12 dependent manner;2, by enhancing the expression of two transcription factors, AhR and c-Maf, that generate Tr1 cells. In this project, we will molecularly define the mechanism by which IL-27 regulates tissue inflammation in EAE by studying the following specific aims: 1) Mechanism by which IL-27 inhibits generation of Th17 cells by studying whether induction of IL-12R?2 chain by IL-27 not only suppresses IL-23R expression but also makes Th17 cells highly responsive to IL-12 and make them plastic to produce IFN-y;2) How IL-27 generates Tr1 cells by studying the role of transcription factors AhR and cMaf and their mutual association in differentiating Tr1 cells. These studies will be accomplished by using AhR, cMaf and AhR x cMaf double """"""""knock-out"""""""" mice;3) Study interplay between Th17 and Tri in the development of tissue inflammation in EAE, using IL-17, IL-10 and FoxP3 reporter mice. These studies will provide a mechanistic basis of how IL-27 suppresses autoimmunity and tissue inflammation in the CNS.

Public Health Relevance

These Studies will provide insight into the mechanisms by which IL-27 suppresses autoimmunity. IFN-?, a first line therapy used in the treatment of MS patients, has been shown to induce IL-27 from innate immune system thus making these studies highly relevant for studying the regulation of autoimmunity and tissue inflammation in the CNS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
1P01NS076410-01A1
Application #
8470945
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
1
Fiscal Year
2013
Total Cost
$326,853
Indirect Cost
$141,229
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Aschenbrenner, Dominik; Foglierini, Mathilde; Jarrossay, David et al. (2018) An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells. Nat Immunol 19:1126-1136
Meyer Zu Horste, Gerd; Przybylski, Dariusz; Schramm, Markus A et al. (2018) Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1. Immunity 48:556-569.e7
Joller, Nicole; Kuchroo, Vijay K (2017) Tim-3, Lag-3, and TIGIT. Curr Top Microbiol Immunol 410:127-156
Karwacz, Katarzyna; Miraldi, Emily R; Pokrovskii, Maria et al. (2017) Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation. Nat Immunol 18:412-421
Hu, Dan; Notarbartolo, Samuele; Croonenborghs, Tom et al. (2017) Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis. Nat Commun 8:1600
Chihara, Norio; Madi, Asaf; Karwacz, Katarzyna et al. (2016) Differentiation and Characterization of Tr1 Cells. Curr Protoc Immunol 113:3.27.1-3.27.10
Anderson, Ana C; Joller, Nicole; Kuchroo, Vijay K (2016) Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. Immunity 44:989-1004
Meyer Zu Horste, Gerd; Wu, Chuan; Wang, Chao et al. (2016) RBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression. Cell Rep 16:392-404
Mayo, Lior; Cunha, Andre Pires Da; Madi, Asaf et al. (2016) IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation. Brain 139:1939-57
Peters, Anneli; Fowler, Kevin D; Chalmin, Fanny et al. (2015) IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling. J Immunol 195:4144-53

Showing the most recent 10 out of 18 publications